Amsterdam UMC / Vrije Universiteit Amsterdam
The Netherlands
History
The Neuromodulation Network was established in 2024 and consists of a diverse group of neuromodulation researchers, including a diverse combination of members based on different neurostimulation techniques, academic backgrounds, countries of origin, career stages and gender.
We are committed to fostering collaboration among researchers, clinicians, and industry leaders to drive innovation in neuromodulation for psychiatric and neurological disorders. By integrating cutting-edge research, technological advancements, and clinical expertise, we aim to enhance precision medicine approaches, optimize treatment efficacy, and expand access to evidence-based neuromodulation therapies. Our network promotes education, knowledge exchange, and translational research, bridging the gap between fundamental neuroscience and real-world clinical applications. Through interdisciplinary partnerships and patient-centered initiatives, we strive to establish neuromodulation as a cornerstone of modern neuropsychiatric treatment, ultimately improving outcomes and quality of life for individuals affected by brain disorders.
Goals
Neuroscience Applied: bridging the gap between basic research and clinical application, we emphasize translational potential and the development of individualized stimulation targets to optimize patient outcomes.
Education and training: we are dedicated to creating comprehensive educational modules and hands-on training opportunities to disseminate knowledge and foster expertise in neuromodulation.
Collaborative research and funding: establishing a platform for collaborative research endeavours, we aim to facilitate funding acquisition for large multinational projects in the neuromodulation field, also aligning with industry partners.
Consensus building through the Delphi Process: We utilize the Delphi method to achieve consensus on critical research questions and methodologies, guiding our research agenda.
Dissemination: we coordinate initiatives to reduce stigma surrounding neurostimulation techniques and support their implementation in areas of need, with active engagement from the public and those with lived experience.
Innovation: we support the exploration of novel neurostimulation methods while addressing regulatory, implementation, and ethical challenges through dedicated task forces.
Interaction: regular online meetings and annual in-person gatherings will ensure ongoing collaboration and knowledge exchange, promoting the formation of specialized subgroups to address specific research challenges.
Core members
Member name | Institution | City | Country |
Ana Ganho Avila | Center for Research in Neuropsychology and Cognitive Behavioral Interventions | Coimbra | Portugal |
Chris Baeken | Ghent University | Ghent | Belgium |
Jean-Marie Batail | Centre Hospitalier Guillaume Régnier / Rennes University | Rennes | France |
Jovana Bjekic | Center for Neuroscience and Neuromodulation / University of Belgrade | Belgrade | Serbia |
Jerome Brunelin | Centre Hospitalier Le Vinatier | Bron | France |
Tiago Costa | Newcastle University / CNTW NHS Trust | Newcastle upon Tyne | United Kingdom |
Annemiek Dols | University Medical Center Utrecht | Utrecht | The Netherlands |
Piotr Jażdżyk | Institute of Psychiatry and Neurology | Warsaw | Poland |
Astrid Kibleur | Université Savoie Mont Blanc | Chambery | France |
Monika Klirova | National Institute of Mental Health / Charles University | Prague | Czechia |
Debby Klooster | Eindhoven University of Technology | Eindhoven | The Netherlands |
Roel Mocking | Amsterdam UMC / University of Amsterdam | Amsterdam | The Netherlands |
Leif Oltedal | Haukeland University Hospital / University of Bergen | Bergen | Norway |
Nils Opel | University Hospital Jena / German Centre for Mental Health | Jena | Germany |
Katya Rubia | Institute of Psychiatry / King's College London | London | United Kingdom |
Sharmili Edwin Thanarajah | Goethe University Frankfurt / University Hospital | Frankfurt | Germany |
Ingo Willuhn | Amsterdam UMC / Netherlands Institute for Neuroscience | Amsterdam | The Netherlands |
Shell members
Member name | Institution | City | Country |
Sara Assecondi | University of Trento | Trento | Italy |
Ralf Berninger | FBI Medizintechnik GmbH | Taufkirchen | Germany |
Bart de Beurs | patient representative from Amsterdam UMC | Amsterdam | The Netherlands |
Bernardo Dell'Osso | University of Milano | Milan | Italy |
Mark Glencorse | LivaNova | London | United Kingdom |
Colleen Hamlin | BrainsWay; Wake Forest University School of Medicine | Winston-Salem, NC | USA |
Andrea Kühn | Charite University Hospital | Berlin | Germany |
Mika Nikander | Sooma Oy | Helsinki | Finland |
Axel Nordenskjold | Orebro University | Orebro | Sweden |
Frank Padberg | Ludwig-Maximilians University Munich | Munich | Germany |
Stefano Pallanti | Institute for Neurosciences | Florence | Italy |
Maria Semkovska | University of Southern Denmark | Odense | Denmark |
Pascal Sienaert | University Psychiatric Centre KU Leuven | Leuven | Belgium |
Veerle Visser-Vandewalle | University of Cologne | Cologne | Germany |
Allan Young | King’s College London | London | United Kingdom |
Early Career Academy member
Member name | Institution | City | Country |
Sara Costi | University of Oxford | Oxford | United Kingdom |
Publications
-
2021Pallanti et al.
Manifesto for an ECNP Neuromodulation Thematic Working Group (TWG): non-invasive brain stimulation as a new uper-subspecialty
European Neuropsychopharmacology -
2021Pallanti et al.
Neuromodulation; TMS (Transcranial Magnetic Stimulation) and the other Non Invasive Brain Stimulation (NIBS) in the era of brain connectivity.
European Neuropsychopharmacology